Recent Earnings Reports Are Looking Good We Are Kicking Off Our Rebound And Hot Sector Reports Tomorrow Near Market Open Good day everyone, January 20...
The Broader Market’s are in Correction Territory. We have a new Biotech company report that will be available tomorrow 01-24-22 at market open.
The Broader Market’s are in Correction Territory We have a new Biotech company report that will be available tomorrow 01-24-22 at market open. ...
A New to the NASDAQ Company That Offers Great Potential with a Robust Biopharma Pipeline, Tiny Market Cap and an Approved Product Ready for Distribution
Good day everyone, We want to report on a company in the biopharma sector that is new to the NASDAQ. This clinical stage company has solid financial m...
Biotricity (NASDAQ: BTCY) Well Positioned With Impressive Revenue Growth and Near-Term Catalysts
Biotricity (BTCY) Could Be a Case Study for a Well Managed Businesses with Their Rapid Growth, Controlled Costs and a New Non-Dilutive Financing Deal ...
I’m Feeling Optimistic About 2022 and Growth in the Markets, Are You? New NASDAQ Report Will be Available Tuesday Dec. 28th Near Market Open.
NASDAQ report coming tomorrow near market open that I’m feeling really good about! Good day everyone and welcome to all of our new trading group membe...
Fed Meeting This Week. We are preparing a report on a tiny float, recent IPO NASDAQ that just entered oversold territory. To be issued Monday 12-13-21 near market open.
Fed Meeting This Week We are preparing a report on a tiny float, recent IPO NASDAQ that just entered oversold territory. To be issued Monday 12-13-21 ...
A Good Week for Our Members and an Upcoming Report on a NASDAQ Biopharma Company with a Solid Pipeline to be Issued Tomorrow 12-08-21 Near Market Open.
Good day everyone, I want to talk about a couple of our recent reports, Citius Pharmaceuticals (CTXR) and Siyata Mobile (SYTA). We alerted CTXR on Mon...
Citius Pharmaceuticals (CTXR) Completes Enrollment in the Pivotal Phase 3 Study of its Cancer Immunotherapy I/ONTAK for the Treatment of Cutaneous T-Cell Lymphoma
Citius Pharmaceuticals (CTXR) Completes Enrollment in the Pivotal Phase 3 Study of its Cancer Immunotherapy I/ONTAK for the Treatment of Cutaneous T-C...
Is the Sell Off in Equities and Crypto Inflation Related or Just Year End Profit Taking and an Update on a Dynamic Bio Company
Is the Sell Off in Equities and Crypto Inflation Related or Just Year End Profit Taking and an Update on a Dynamic Bio Company New report coming at ma...
This junior gold miner has potentially massive gold reserves with a float of around 6M shares. Trading at less than half of a recently issued price target.
This junior gold miner has potentially massive gold reserves with a float of around 6M shares. Trading at less than half of a recently issued price ta...
